Skip to main content
Clinical Papers
28 women with photodamage underwent a picosecond laser treatment with the Resolve 1064 nm handpiece, using low energy fluence of 1.1 J/cm2 or high energy treatment (2.1 J/cm2). High energy group showed significant improvement with a more pronounced effect on facial skin than low energy treatments. Histopathological examination of biopsies at 3 weeks’ post-treatment showed a marked elevation in collagen type III expression antibodies in the high fluence group.
Clinical Papers
20 subjects were randomly assigned to split-face treatment with PicoWay Resolve (532/1064 nm picosecond lasers) treatment to one side of the face and 1927 nm fractionated thulium fiber laser (TFL) to the contralateral side. Blinded, non‐treating evaluator assessments of photodamage at 6-month follow-up showed statistically significant improvements in photodamaged skin in both treatment groups, but with less downtime associated with Resolve treatments.
Clinical Papers
Retrospective chart and photographic review of 233 patients treated with PicoWay and Resolve handpieces for nontattoo indications. Blinded review of treatment outcome showed that every type of skin lesion exhibited improvement; epidermal nevi exhibited the greatest improvement with treatment and acne scarring the least improvement.
Marketing Education
Frost & Sullivan invited leading physicians to participate in a new and unique thought leadership forum, the virtual Think Tank series. This forum brought together leading minds in healthcare to discuss best practices in treating skin of color.